Companies: 10,795·Total market cap: $144.5T
Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd

HKPDNASDAQHealthcare● Active
$0.49
$-0.01(-2.06%)
Market Cap$5432584
P/E Ratio—
52W High$2.58
52W Low$0.37
Overview
股票排行：Medical - Pharmaceuticals·Healthcare·查看全部市值排行 →

Cellyan Biotechnology Co., Ltd（HKPD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HKPD · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.15hkpd eps ttm · hkpd earnings per shareEarnings history
PE Ratio (TTM)3.4×hkpd pe ratio ttm · hkpd price to earningsPE Ratio deep dive
Revenue (TTM)$37.0Mhkpd revenue ttm · hkpd annual revenueFull revenue history
Dividend Yield不分红does hkpd pay dividends · hkpd dividend yieldDividend history
Shares Outstanding9.0Mhkpd shares outstanding · hkpd floatShares outstanding history
Next EarningsTBAhkpd earnings date · hkpd next earningsEarnings history

探索 Cellyan Biotechnology Co., Ltd 数据

hkpd stock data · financials
市值$5.4Mhkpd market cap · hkpd valuation
分析师预测—
股息不分红does cellyan biotechnology co., ltd pay dividends · hkpd dividend yield
营收$20.3M+21.72%cellyan biotechnology co., ltd annual revenue · hkpd revenue
盈利EPS $-0.00-101.50%hkpd earnings · hkpd eps
市盈率3.4×hkpd pe ratio · hkpd price to earnings

财务快照

完整财报
FY 2025Revenue$20.3M▲ +21.72% YoY
202320242025
cellyan biotechnology co., ltd revenue · hkpd revenue 2025
FY 2025Net Income-$27056.00▼ 102.03% YoY
202320242025
cellyan biotechnology co., ltd net income · hkpd profit 2025
FY 2025EPS$-0.00▼ 101.50% YoY
202320242025
hkpd eps · cellyan biotechnology co., ltd earnings per share 2025
TTM:Revenue: $37.0MNet Income: $1.3MEPS: $0.15View income statement →

股票表现

完整历史
1D-2.06%
1W-3.04%
1M-20.50%
3M-23.86%
YTD-39.98%
1Y-76.99%
5Y-82.45%

关于 Cellyan Biotechnology Co., Ltd

CEOChenyu Liang
IPO DateJan 15, 2025
Employees27
CountryHK
Website9zt.hk

Cellyan Biotechnology Co., Ltd an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cr…

Medical - PharmaceuticalsHealthcareNASDAQHK

what is cellyan biotechnology co., ltd · hkpd stock overview · cellyan biotechnology co., ltd company profile · who is cellyan biotechnology co., ltd ceo · hkpd NASDAQ · cellyan biotechnology co., ltd headquarters · cellyan biotechnology co., ltd business segments

关于股票概览与关键数据

Cellyan Biotechnology Co., Ltd（HKPD）是 Medical - Pharmaceuticals 行业的 Healthcare 类公司，于 Jan 15, 2025 在 NASDAQ 上市。截至最近交易日，HKPD 股价为 $0.49，市值约为 $5.4M。过去12个月累计回报 -76.99%，年初至今回报 -39.98%。

2025 财年 Cellyan Biotechnology Co., Ltd 营收 $20.3M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Cellyan Biotechnology Co., Ltd（HKPD）股价为 $0.49，在 NASDAQ 上市，52周区间为 $0.37 – $2.58。

HKPD 最新股价HKPD quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议